http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005025540-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efa70e241ba9713f5da68f2bfeea7fbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cf99584da7cb1936597e19b32da289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a85fb4f3f01ad99d77a76fb1434c9d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c45987eeb4687d119f243265a6c5875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bfe97e6d5e5f4698561f8c5df2f213f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-12
filingDate 2004-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7890f6f899eda1fe0f92fc186e49ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9041dc46c9bc7034e1a00ee3b840aefe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec332b5d35c73b6d7b52f7a9a909cb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df6499f9e915eef5b7d531260a81498
publicationDate 2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005025540-A3
titleOfInvention Mucoactive agents for treating a pulmonary disease
abstract The present invention relates to mucoactive agents, such as heparin which are useful in the treatment of diseases where excess mucus is present in the respiratory tract, such as cystic fibrosis and chronic obstructive pulmonary disease. In particular, the invention relates to pharmaceutical compositions for administration by pulmonary inhalation. It also relates to methods for producing particles suitable for pulmonary inhalation, such as spray drying or jet milling.
priorityDate 2003-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115672-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9402107-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9906025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9804133-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238

Total number of triples: 37.